公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study | CHIUN HSU ; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; CHIH-WEI YU ; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG | Journal of Hepatology | 79 | 74 | |
2014 | Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin | DA-LIANG OU ; Lee B.-S.; LIANG-IN LIN ; Liou J.-Y.; Liao S.-C.; CHIUN HSU ; ANN-LII CHENG | Molecular Cancer | 40 | 33 | |
2008 | Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma | Hsiao S.-M.; CHI-AN CHEN ; CHIUN HSU ; HO-HSIUNG LIN ; CHANG-YAO HSIEH ; LING-HUNG WEI | Anticancer Research | 2 | 1 | |
2004 | Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract | CHIUN HSU ; Ying-Chun Shen ; CHIH-HSIN YANG ; KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG | British Journal of Cancer | 42 | 40 |